Angelini Ventures
Approach
We empower health innovation through capital, expertise, and global reach
Biotech
This sector pioneers healthcare transformation, integrating biology, technology, and medicine.
With breakthroughs in synthetic biology, gene editing, AI/ML, and regenerative medicine, it tackles urgent medical issues at the forefront.
Techbio
This is an emerging segment at the intersection of data, AI, and biotechnology transforming the landscape of drug development through advanced technology.
This sector is pioneering sustainable biotech platforms offering new potentials for innovation and efficacy.
Connected Health Devices
These devices represent a burgeoning opportunity, leveraging data and AI to offer diversified treatment, diagnostic, and monitoring solutions leading to personalized care. Notably, neurostimulation devices exemplify the potential of CHD to address large markets with significant unmet needs.
Digital Diagnostics (DDX) & Digital Therapeutics (DTX)
The digital health sector is growing rapidly due to technological advancements, increasing healthcare costs, and the need for more accessible solutions.
Digital diagnostics (DDx) and therapeutics (DTx) are leading this transformation, offering innovative approaches to diagnosis and treatment.
Hybrid Care Platforms
Global healthcare systems face challenges due to the growing demand for services. Hybrid Care Platforms improve the efficiency of providing high quality care. They combine digital, virtual and physical approaches to provide innovative solutions for diagnosis, treatment, and support addressing the demand-supply gap.
Do you represent an innovative company with the potential to shape the future of care that meets the criteria described on this page?